BRAINTEASER project aims to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. “Amyotrophic Lateral Sclerosis” campaign wants to bring attention to this condition and analyse the variables that might affect its progression. In “The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis” M. Kelly et al. report the results of an exploratory, non-controlled, nondrug study that aimed to objectively monitor ALS patients at home, to explore novel disease progression markers.
[Get to Know more about Amyotrophic Lateral Sclerosis] The use of biotelemetry to explore disease
OUR NEWSLETTER
Latest posts
BRAINTEASER impact and exploitation workshop: driving innovation from lab to market
BRAINTEASER’s liaison activities are fostering synergies in brain research to maximise impact,...
Harnessing AI for brain health: lab to market to society
Bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and...
“Living with her” Amyotrophic Lateral Sclerosis – An interview with Raquel Estúñiga Dominguez
Do you also forget the realities that don’t seem so close to you? Realities like Raquel Estúñiga...